Profil
Walter O.
Fredericks has been a Director of Matritech, Inc. since July 2003.
From 2002 to 2006, Mr. Fredericks was a Member of Financial Affairs for Adirondack Boat LLC.
From 1991 to 2001, he was President, Chief Executive Officer and a Director of Lifecodes Corp.
Mr. Fredericks was Founder of Electronic Instruments International and Chief Executive Officer and a Director from 1993 to 2001.
From 1989 to 1997, he was a Director of DIANON Systems, Inc.
Anciens postes connus de Walter O. Fredericks
| Sociétés | Poste | Fin |
|---|---|---|
MZT Holdings, Inc.
 MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | Directeur/Membre du Conseil | 22/01/2008 |
Matritech, Inc.
 Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Directeur/Membre du Conseil | 13/12/2007 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Matritech, Inc.
Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Health Technology |
MZT Holdings, Inc.
MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | Health Technology |
